Our group is using chemical knowledge and computational techniques to design and synthesize sugar mimics, based on known structural properties of bioactive oligosaccharides and of their protein complexes.
Our expertise includes:
– synthesis of biologically active compounds and glycomimetics
– computer- aided drug design of new biologically active compounds
– structure- and ligand-based design of receptor antagonists